Reuters: Express Scripts targets new migraine drugs to change U.S. pricing dynamic

Reuters: Express Scripts targets new migraine drugs to change U.S. pricing dynamic

The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken